How to evaluate a proposed cell product

A condition name alone cannot determine a cell type, dose or delivery route. Those choices depend on the exact product, indication, evidence, regulatory status and an individual clinical assessment.

Ask for the exact product, not a broad label

Product name, cell source, donor relationship and processing method.
Proposed indication, route, dose and number of administrations.
Current authorisation or trial identifier for that exact use.
Manufacturing authorisation, release tests, traceability and adverse-event plan.
Primary clinical evidence and realistic alternatives, reviewed by an independent physician.

This page does not select a treatment. Start with the condition evidence pages, verify registered studies on ClinicalTrials.gov, and use the clinic-verification checklist.

Compare cell-therapy evidence, registered studies and published price observations.

StemCellAtlas is a source-first research and cost-planning guide. It separates registry and regulator evidence from heterogeneous commercial observations.

Get an honest assessment